105 U.S. Reps., 28 U.S. Senators Urge Trump Administration to Fix Pharmacy DIR Fees Pharmacy groups unite to laud bipartisan Congressional focus on closing the loophole that inflates drug costs for patients and Medicare, and jeopardizes pharmacies

By |2019-06-20T11:49:41-04:00Jun-20-19|Categories: Press Release|Tags: , , , |

Pharmacy groups unite to laud bipartisan Congressional focus on closing the loophole that inflates drug costs for patients and Medicare, and jeopardizes pharmacies.

Pharmacy United in Call for President Trump to Act on DIR Fee Reform Bipartisan support is strong for a legislative fix to the loophole that inflates drug costs for patients and for Medicare, and that jeopardizes pharmacies

By |2019-06-19T11:00:59-04:00Jun-10-19|Categories: Press Release|Tags: , , |

Bipartisan support is strong for a legislative fix to the loophole that inflates drug costs for patients and for Medicare, and that jeopardizes pharmacies.

NCPA, NACDS Statement on Drug Pricing Rule’s Failure to Reform Pharmacy DIR

By |2019-06-19T11:33:03-04:00May-16-19|Categories: Press Release|Tags: , , |

NCPA and NACDS: "We are disappointed and frustrated that this final rule fails to finalize pharmacy DIR reform as proposed, to the detriment of seniors and community pharmacies. Our organizations have been joined by many pharmacists, pharmacy stakeholder groups, patient advocacy organizations, patients, and members of Congress in advocating that all pharmacy price concessions be included at the point of sale – or eliminated altogether – to provide senior patients with lower costs and pharmacies with more certainty..."

As HHS’ Azar Testifies, NACDS Urges His DIR Reform Proposals NACDS’ Congressional statement keys on lowering patients’ costs at pharmacy counter, reducing overall healthcare costs, and fostering pharmacy viability by preventing below-cost reimbursement

By |2019-06-19T12:26:21-04:00Mar-14-19|Categories: Press Release|Tags: , , , , , |

NACDS’ Congressional statement keys on lowering patients’ costs at pharmacy counter, reducing overall healthcare costs, and fostering pharmacy viability by preventing below-cost reimbursement.

NACDS Urges DIR Fee Reform in Morning Consult Op-Ed NACDS President & CEO Steven C. Anderson emphasizes DIR fee reform’s role in lowering patients’ out of pocket costs, reducing overall healthcare costs

By |2019-06-19T12:03:06-04:00Mar-08-19|Categories: Press Release|Tags: , , , , , |

Morning Consult today published an opinion piece by the NACDS entitled “DIR Fee Reform: Lining Up Another Win for Patients on Drug Costs.”

Load More Posts